Anti-coronavirus vaccines will not accelerate the transition of humanity to a non-pandemic period, but the pandemic will take fewer victims.
COVID-19
Immunity
Immunological memory
Pandemic
Reinfection
SARS-CoV-2
Vaccine
Journal
Inflammation research : official journal of the European Histamine Research Society ... [et al.]
ISSN: 1420-908X
Titre abrégé: Inflamm Res
Pays: Switzerland
ID NLM: 9508160
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
17
01
2022
accepted:
21
03
2022
revised:
17
03
2022
pubmed:
11
4
2022
medline:
9
6
2022
entrez:
10
4
2022
Statut:
ppublish
Résumé
The vaccination rate worldwide has reached enormous proportions, and it is likely that at least 75% of the world's population will be vaccinated. The controversy is that, while people aged 65 and older suffer a significantly higher mortality rate from COVID-19, plans are being made to vaccinate young people under the age of 20. Equally thorny is the question of vaccinating people who already have antibodies to SARS-CoV-2, as well as B and T memory cells, because they contracted and survived the virus. The possible consequences of large-scale vaccination are difficult to predict, when some people do not have access to the vaccine at all and others have already received 3 doses of the vaccine. SARS-CoV-2 will circulate through the human population forever and continue to mutate, as viruses do. Therefore, in the coming years, the need to develop and use effective vaccines and medicines for the prevention and treatment of COVID-19 will remain urgent in view of the high mortality rate from this disease. To date, three vaccine platforms have been most used: adenoviral vector, inactivated, and mRNA. There is some concern about the side effects that occur after vaccination. Whether modern anti-coronavirus vaccines can raise the safety threshold, only time will answer. It is obvious that the pandemic will end, but the virus will remain in the human population, leaving behind invaluable experience and tens of millions of victims. This article is based on search retrieves in research articles devoted to COVID-19 mainly published in 2020-2021 and examines the possible consequences of the worldwide vaccination against SARS-CoV-2 and suggests that, while anti-coronavirus vaccines will not magically transport humanity to a non-pandemic world, they may greatly reduce the number of victims of the pandemic and help us learn how to live with COVID-19.
Identifiants
pubmed: 35397666
doi: 10.1007/s00011-022-01567-1
pii: 10.1007/s00011-022-01567-1
pmc: PMC8994861
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
521-536Subventions
Organisme : Ministry of Science and Higher Education of the Russian Federation
ID : No. FZEG-2021-0009
Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Références
Lancet Infect Dis. 2022 Jan;22(1):56-63
pubmed: 34509185
J Pers Med. 2021 Oct 02;11(10):
pubmed: 34683141
Natl Sci Rev. 2021 Dec 04;9(2):nwab220
pubmed: 35211321
Mol Ther. 2014 Dec;22(12):2118-2129
pubmed: 25027661
China CDC Wkly. 2020 Jan 24;2(4):61-62
pubmed: 34594763
Lancet Respir Med. 2021 Nov;9(11):1255-1265
pubmed: 34391547
Front Immunol. 2020 Dec 23;11:602256
pubmed: 33424848
BMJ. 2021 Sep 13;374:n2101
pubmed: 34518194
Rev Med Virol. 2022 Jan;32(1):e2260
pubmed: 34043841
Front Immunol. 2021 Feb 24;12:640093
pubmed: 33717193
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Age Ageing. 2021 Feb 26;50(2):279-283
pubmed: 33320183
Sci Rep. 2020 Oct 6;10(1):16642
pubmed: 33024235
PLoS Biol. 2021 Apr 29;19(4):e3001237
pubmed: 33914735
J Infect Dis. 2021 Feb 13;223(3):409-415
pubmed: 32692346
Mol Ther. 2001 May;3(5 Pt 1):697-707
pubmed: 11356075
Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
J Infect Dis. 2003 Apr 15;187(8):1257-63
pubmed: 12696005
Lancet Infect Dis. 2021 Nov;21(11):1529-1538
pubmed: 34174193
Nature. 2021 Sep;597(7876):318-324
pubmed: 34522017
Science. 2020 Oct 30;370(6516):564-570
pubmed: 32912998
Vaccine. 2011 Sep 2;29(38):6670-8
pubmed: 21745520
Nat Rev Immunol. 2021 Oct;21(10):626-636
pubmed: 34373623
NPJ Vaccines. 2021 Aug 5;6(1):97
pubmed: 34354082
Int J Antimicrob Agents. 2020 Aug;56(2):106080
pubmed: 32634603
Int J Infect Dis. 2021 Sep;110:258-260
pubmed: 34157386
JAMA. 1973 May 21;224(8):1170-1
pubmed: 4739864
Nature. 2020 Oct;586(7830):567-571
pubmed: 32756549
J Occup Environ Med. 2016 Dec;58(12):1159-1166
pubmed: 27930472
Nat Commun. 2020 Nov 18;11(1):5885
pubmed: 33208793
Mol Ther. 2020 Nov 4;28(11):2303-2304
pubmed: 33065038
J Virol. 2003 Aug;77(15):8263-71
pubmed: 12857895
Nat Microbiol. 2020 Oct;5(10):1185-1191
pubmed: 32908214
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
Prev Med. 2021 Sep;150:106694
pubmed: 34171345
N Engl J Med. 2021 Apr 15;384(15):1412-1423
pubmed: 33626250
Lancet. 2021 Feb 20;397(10275):642-643
pubmed: 33545098
Vaccine. 2013 Apr 18;31 Suppl 2:B61-72
pubmed: 23598494
Virology. 1996 May 1;219(1):220-7
pubmed: 8623532
Nature. 2010 May 13;465(7295):161
pubmed: 20463719
J Virol. 2003 Sep;77(18):10078-87
pubmed: 12941918
Therapie. 2021 Jul-Aug;76(4):369-373
pubmed: 34083026
Lancet Infect Dis. 2021 Jun;21(6):803-812
pubmed: 33548194
Kidney Int. 2021 Aug;100(2):473-474
pubmed: 34081948
Nat Commun. 2021 Jun 30;12(1):4043
pubmed: 34193870
Nature. 2021 Aug;596(7870):109-113
pubmed: 34182569
Pediatrics. 2001 May;107(5):1147-54
pubmed: 11331700
Lancet Infect Dis. 2022 Jan;22(1):43-55
pubmed: 34480857
Science. 2020 Sep 11;369(6509):1309-1312
pubmed: 32883884
N Engl J Med. 2021 Sep 2;385(10):875-884
pubmed: 34233097
Science. 1990 Mar 23;247(4949 Pt 1):1465-8
pubmed: 1690918
J Virol. 2009 May;83(9):4386-94
pubmed: 19211743
Proc Natl Acad Sci U S A. 2022 Mar 1;119(9):
pubmed: 35165203
Lancet. 2021 Apr 17;397(10283):1459-1469
pubmed: 33844963
JAMA. 2021 Jul 13;326(2):185-188
pubmed: 34106201
Immunol Rev. 2000 Feb;173:89-97
pubmed: 10719670
Mol Ther Methods Clin Dev. 2016 Apr 27;3:16030
pubmed: 27162933
Sci Rep. 2021 Jun 15;11(1):12530
pubmed: 34131216
Nucleic Acids Res. 2011 Nov;39(21):e142
pubmed: 21890902
Lancet Reg Health Eur. 2021 Mar;2:100044
pubmed: 34173633
Biomed J. 2021 Mar;44(1):18-30
pubmed: 33727051
J Am Geriatr Soc. 2020 May;68(5):912-917
pubmed: 32212386
Methods. 2022 May;201:15-25
pubmed: 33882362
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Nat Rev Drug Discov. 2018 Apr;17(4):261-279
pubmed: 29326426
Lancet. 2006 Feb 11;367(9509):475-81
pubmed: 16473124
Science. 2021 Feb 5;371(6529):
pubmed: 33408181
N Engl J Med. 2020 Dec 17;383(25):2427-2438
pubmed: 32991794
Inflamm Res. 2020 Sep;69(9):801-812
pubmed: 32656668
Arch Gerontol Geriatr. 2021 Sep-Oct;96:104487
pubmed: 34280598
Proc Natl Acad Sci U S A. 2021 Jan 5;118(1):
pubmed: 33335073
J Virol. 1985 Jun;54(3):711-9
pubmed: 3999192
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Immune Netw. 2021 Feb 15;21(1):e6
pubmed: 33728099
PLoS One. 2012;7(4):e35421
pubmed: 22536382
Vaccine. 2014 Nov 12;32(48):6377-89
pubmed: 24975812
Nature. 2021 Sep;597(7875):166-168
pubmed: 34493845
J Investig Med. 2021 Aug;69(6):1253-1255
pubmed: 34006572
Hum Vaccin Immunother. 2016 Sep;12(9):2351-6
pubmed: 27269431
Vaccine. 2020 Jul 22;38(34):5418-5423
pubmed: 32600908
Science. 2020 May 29;368(6494):945-946
pubmed: 32385100
J Virol. 2011 Jun;85(11):5565-70
pubmed: 21411537
NPJ Vaccines. 2020 Sep 28;5:91
pubmed: 33083026
Lancet Infect Dis. 2021 Feb;21(2):181-192
pubmed: 33217362
Hum Vaccin Immunother. 2017 Dec 2;13(12):2837-2848
pubmed: 28604157
Nature. 2021 Oct;598(7881):393-394
pubmed: 34650244
Immunity. 2021 Feb 9;54(2):205-210
pubmed: 33513337
NPJ Vaccines. 2021 May 21;6(1):77
pubmed: 34021159
J Clin Med. 2021 Jun 15;10(12):
pubmed: 34203769
Clin Immunol. 2021 Jan;222:108634
pubmed: 33217545
Toxicol Rep. 2021;8:871-879
pubmed: 33898273
J Virol. 2006 Nov;80(22):11241-54
pubmed: 16956941
Nature. 2021 Jan 15;:
pubmed: 33452510
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Front Immunol. 2020 Nov 06;11:589833
pubmed: 33240278
Life (Basel). 2021 Mar 17;11(3):
pubmed: 33803014
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Eur J Epidemiol. 1988 Mar;4(1):12-9
pubmed: 3128450